What is the address of BELLEFARMA?

The registered office of BELLEFARMA is located at Lubbeeksestraat 17, 3370 Boutersem.

Is BELLEFARMA still active?

Yes. According to the CBE (29 October 2026) BELLEFARMA is active, legal situation “Normale toestand”, started on 7 July 2004.

Is BELLEFARMA registered on Peppol?

Yes, BELLEFARMA is registered on the Peppol network with ID 0208:0866332041.

What is the enterprise number of BELLEFARMA?

The enterprise number of BELLEFARMA is BE0866332041.

When was BELLEFARMA founded?

BELLEFARMA was founded on 7 July 2004.

Who are the directors of BELLEFARMA?

According to the 2025 annual accounts, the directors of BELLEFARMA are: Isabella Stalpaert.

Is BELLEFARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 7 July 2004; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did BELLEFARMA make in 2025?

BELLEFARMA posted a profit after taxes of € 179,129 in financial year 2025.

What is the revenue of BELLEFARMA?

As a small company, BELLEFARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 112,957.

BELLEFARMA (Private Limited) - Boutersem - BE0866332041

Q: What does BELLEFARMA do?

BELLEFARMA is registered with the CBE as active in: Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies. Private Limited, started on 7 July 2004, 1 establishment.

Dossier BELLEFARMA, printed on 29 October 2026 from databakkes.be/en/0866332041/bellefarma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

BELLEFARMA from Boutersem, company number BE0866332041, closed financial year 2025 with a result of € 179,129 after tax. For that financial year BELLEFARMA recorded a gross margin of € 112,957 and equity of € 1.8 million. Compared with financial year 2024, the result moved from € 159,467 to € 179,129. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 23, 2026.

What it is worth Growing

€ 1.8 million

▲ 11% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 179,129

▲ 12% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 793,197

▲ 5% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 1.8 million.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 1,711

▲ € 1,631 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 7,045

▼ 45% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 249,981 Gross margin 2022: € 249,981 First fiscal year in the series	€ 216,335 Gross margin 2023: € 216,335 ▼ 13% vs 2022 (€ 249,981) Unfavourable step	€ 236,391 Gross margin 2024: € 236,391 ▲ 9% vs 2023 (€ 216,335) Favourable step	€ 112,957 Gross margin 2025: € 112,957 ▼ 52% vs 2024 (€ 236,391) Unfavourable step	▼ 52%
Profit after taxes	€ 170,415 Profit after taxes 2022: € 170,415 First fiscal year in the series	€ 145,738 Profit after taxes 2023: € 145,738 ▼ 14% vs 2022 (€ 170,415) Unfavourable step	€ 159,467 Profit after taxes 2024: € 159,467 ▲ 9% vs 2023 (€ 145,738) Favourable step	€ 179,129 Profit after taxes 2025: € 179,129 ▲ 12% vs 2024 (€ 159,467) Favourable step	▲ 12%
Equity	€ 1,312,929 Equity 2022: € 1,312,929 First fiscal year in the series	€ 1,458,667 Equity 2023: € 1,458,667 ▲ 11% vs 2022 (€ 1,312,929) Favourable step	€ 1,618,134 Equity 2024: € 1,618,134 ▲ 11% vs 2023 (€ 1,458,667) Favourable step	€ 1,797,263 Equity 2025: € 1,797,263 ▲ 11% vs 2024 (€ 1,618,134) Favourable step	▲ 11%
Total debts	€ 240,999 Total debts 2022: € 240,999 First fiscal year in the series	€ 254,539 Total debts 2023: € 254,539 ▲ 6% vs 2022 (€ 240,999) Unfavourable step	€ 243,522 Total debts 2024: € 243,522 ▼ 4% vs 2023 (€ 254,539) Favourable step	€ 256,641 Total debts 2025: € 256,641 ▲ 5% vs 2024 (€ 243,522) Unfavourable step	▲ 5%
Cash	€ 531,595 Cash 2022: € 531,595 First fiscal year in the series	€ 736,195 Cash 2023: € 736,195 ▲ 38% vs 2022 (€ 531,595) Favourable step	€ 752,488 Cash 2024: € 752,488 ▲ 2% vs 2023 (€ 736,195) Favourable step	€ 793,197 Cash 2025: € 793,197 ▲ 5% vs 2024 (€ 752,488) Favourable step	▲ 5%
Retained profit	€ 1,306,729 Retained profit 2022: € 1,306,729 First fiscal year in the series	€ 1,452,467 Retained profit 2023: € 1,452,467 ▲ 11% vs 2022 (€ 1,306,729) Favourable step	€ 1,611,934 Retained profit 2024: € 1,611,934 ▲ 11% vs 2023 (€ 1,452,467) Favourable step	€ 1,791,063 Retained profit 2025: € 1,791,063 ▲ 11% vs 2024 (€ 1,611,934) Favourable step	▲ 11%
Balance sheet total	€ 1,553,928 Balance sheet total 2022: € 1,553,928 First fiscal year in the series	€ 1,713,206 Balance sheet total 2023: € 1,713,206 ▲ 10% vs 2022 (€ 1,553,928) Unchanged	€ 1,861,656 Balance sheet total 2024: € 1,861,656 ▲ 9% vs 2023 (€ 1,713,206) Unchanged	€ 2,053,904 Balance sheet total 2025: € 2,053,904 ▲ 10% vs 2024 (€ 1,861,656) Unchanged	▲ 10%

Key figures of BELLEFARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to BELLEFARMA?

What happened at BELLEFARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 23, 2026 New annual accounts for financial year 2025: profit of € 179,129 (▲ 12% vs 2024). filed late Source: NBB ↗
Oct 1, 2004 New establishment in Boutersem. KBO
Jul 7, 2004 Start of the company according to the CBE. KBO

In short

From € 170,415 profit in 2022 to € 179,129 profit in 2025.

Paid € 242,809 in corporate taxes since 2022.

Best year ever: 2025, with € 179,129 profit.

Original PDFs at the National Bank ↗

Management

Isabella Stalpaert

BELLEFARMA

Apotheek Stalpaert 99.9%

Behind BELLEFARMA is Isabella Stalpaert. It owns 99.9% of Apotheek Stalpaert itself.

Directors

According to the 2025 annual accounts

Isabella Stalpaert

Director

Also active at: APOTHEEK STALPAERT

Establishments

Establishment units

Physical locations of this company

Registered office

Lubbeeksestraat 17

3370 Boutersem

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.

All companies at this address →

APOTHEEK STALPAERT same network

€ 310,903 gross margin · 2025

LICENTIA

€ 198,209 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0866.332.041

VAT number

BE 0866.332.041

Registered office

Lubbeeksestraat 17, 3370 Boutersem

Names & denominations

BELLEFARMA

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

7 July 2004

Peppol

Active · Active since 18 Jul 2025

Activities · NACE

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsvoering en beheer

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

BELLEFARMA

Financials

What happened to BELLEFARMA?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions